Evidence-Driven Advocacy sm
Health and biosciences issues are at the core of today's greatest policy debates. The FaegreBD Consulting Health &
Biosciences Practice group offers advisory and advocacy services to health care providers, pharmaceutical companies, medical device manufacturers, industry groups and voluntary health associations. Our strategic counsel helps clients navigate these often-changing, complex and challenging policy areas.
FaegreBD Consulting seamlessly integrates specialized political support with expert regulatory and reimbursement consulting to create opportunities within government sectors and avert government-imposed problems. Our technical and scientific consultants steer a product through complex government regulatory hurdles and payer review. Our government affairs consultants' efforts range from preserving
a single profit center of an individual health care company to developing support for an entire industry or patient population.
Designing Innovative Medical Research Systems
One of the biggest hurdles on the path to faster medical cures is a growing disconnect between academia and industry. A panel of experts from across the medical research spectrum assembled during the 2010 Milken Institute Global Conference to discuss this issue.
Debra Lappin, senior vice president of FaegreBD Consulting and President of the Council for American Medical Innovation, led the discussion. To view a video of this dialogue
Our work is broad-gauged, spanning not only the technical requirements of governments and other third-party payers but also the policy, political and consumer forces that shape the multifaceted heath care industry. Core functions include:
- Government Affairs - Crafting evidence-driven solutions for resolving tensions between health care technologies and health care budgets, creating partnerships between federal agencies and constituent groups, developing and managing national coalitions, crafting amendments for funding assistance, and securing regulatory relief;
- Public Affairs - Identifying and recruiting advocates, determining key audiences, and tailoring messages through thoughtful outreach tactics and timing;
- Reimbursement/Regulatory Strategy - Developing a genuine strategy with the ability to "see" across key areas, including product evidence and policy planning; and
- Reimbursement Support - Providing discrete services to achieve reimbursement-related objectives, including product launches, coverage and coding.
Our healthcare experts come from the highest ranks of health and bioscience firms and associations, the upper levels of government sectors and public affairs practices. We bring a keen understanding of the relationship between government and health policy through our expertise in working with leadership in the U.S. Congress, the Centers for Disease Control and Prevention (CDC), the Centers for Medicare and Medicaid Services (CMS), the Food and Drug Administration (FDA), and National Institutes for Health (NIH).
Collectively as consultants, we have served a wide range of pharmaceutical, biotech and device companies, providers, patient advocacy associations and coalitions where our health issue expertise, Washington political contacts and grassroots organizing capabilities often work in tandem. Most importantly, we have a proven track record of exceeding client expectations.
In short, we know what works and how to get the job done.